Consumer products giant Procter and Gamble is applying its knowledge of consumers to the development of new medicines – and wants to share its insights with biotech companies.
Biotech crops may finally be breaking through to the commercial mainstream in Europe, with a 77 perc ent increase in planting between 2006 and 2007, according to data released this week.
Researchers using the European Synchrotron Radiation Facility, and working with scientists, have become the first to elucidate the structure of a membrane protein, an important advance for drug discovery.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.